Product Details for: Skytrofa
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
For Injection
Subcutaneous
3MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
002
For Injection
Subcutaneous
3.6MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
003
For Injection
Subcutaneous
4.3MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
004
For Injection
Subcutaneous
5.2MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
005
For Injection
Subcutaneous
6.3MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
006
For Injection
Subcutaneous
7.6MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
007
For Injection
Subcutaneous
9.1MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
008
For Injection
Subcutaneous
11MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
009
For Injection
Subcutaneous
13.3MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
010
For Injection
Subcutaneous
0.7MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
011
For Injection
Subcutaneous
1.4MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
012
For Injection
Subcutaneous
1.8MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
013
For Injection
Subcutaneous
2.1MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
014
For Injection
Subcutaneous
2.5MG
Single-Dose Cartridge
351(a)
Skytrofa
Rx
Proper Name
lonapegsomatropin-tcgd
lonapegsomatropin-tcgd
BLA Number
761177
761177
Applicant
Ascendis Pharma Endocrinology Division A/S
Ascendis Pharma Endocrinology Division A/S
Original Approval Date
August 25, 2021
August 25, 2021
Date of First Licensure